Promotie onderzoek

KNMP stelt wetenschappelijk onderzoek voorop. Hier kunt u de meest recente onderzoeken vinden.
Er zijn22resultaten gevonden
Medicatieveiligheid

Transitional care in geriatric patients

  • Universiteit Universiteit Utrecht
  • Promovendus Lotte Falke
  • Promoters Toine Egberts, Marcel Bouvy
  • Co-Promoters Fatma Karapinar, Wilma Knol
  • Jaar 2022-2028

Financiering UU/docentschap.
 

Medicatieveiligheid

Farmaceutische patiƫntenzorg

  • Universiteit Amsterdam Universitair Medisch Centrum
  • Promovendus Selma En-Nasery
  • Promoters Jacqueline Hugtenburg
  • Co-Promoters Fatma Karapinar, Pierre Bet
  • Jaar 2019-2025/2026
Communicatie

Flourishing diversity through constructive conversations on the workplace in healthcare

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Madzy Maljaars-Hendrikse
  • Promoters Hugo van der Kuy
  • Co-Promoters Wim Rietdijk
  • Jaar 2023-2028

Amid the dynamic and high-pressure healthcare environment, workplace conversations are often strained. We investigate the essential skills healthcare professionals need to navigate these challenges. To address this, we developed a scalable e-learning program focused on conflict resolution. This study evaluates the program's impact on communication and teamwork, aiming to enhance workplace culture, collaboration, and patient care.
 

Medicatieveiligheid

Optimizing therapy in patients suffering from statin-intolerance: n=1 trials.

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Ruben Mijnster
  • Promoters Hugo van der Kuy
  • Co-Promoters Melvin Lafeber Jeanine Roeters-van Lennep
  • Jaar 2024-2028

My research focuses on the occurence of nocebo-effects in statin-intolerant. We try to identify patients who are statin-intolerant and that suffer from these effects. We hope that by identifying patients affected by the nocebo effect and allowing them to experientially understand its impact through an N=1 study design, they will experience fewer side effects from their statin treatment. This may help prevent the need to switch to expensive PCSK9 inhibitors.
 

Medicatieveiligheid

Improving pharmaceutical care for hospitalized patients

  • Universiteit Erasmus Medisch Centrum Rotterdam
  • Promovendus Sarah Wilkes
  • Promoters Hugo van der Kuy
  • Co-Promoters Rianne Zaal
  • Jaar 2022-2026

Cost benefit analysis clinical medication reviews. Follow up of interventions from clinical pharmacists. Medication information needs of hospitalized patients.
 

Medicatieveiligheid

Patient care in bariatric surgery

  • Universiteit Leiden Universitair Medisch Centrum
  • Promovendus Jurjen Kingma
  • Promoters Catharijne Knibbe, Patrica van den Bemt
  • Co-Promoters Marcel van den Broek
  • Jaar 2019-2025
Medicatieveiligheid

Dual and triple anticoagulation safety

  • Universiteit Universitair Medisch Centrum Groningen
  • Promovendus Renate van Uden
  • Promoters Patricia van den Bemt, Karina Meijer
  • Co-Promoters Matthijs Becker, Marcia Vervloet
  • Jaar 2018-2025
Pagina 3 van 4